AAO Commends Congress for Reaching Significant Milestone on Prior Authorization Reform Bill

The American Academy of Ophthalmology stated that is commends the US House of Representatives for surpassing the 290-cosponsor milestone in support of H.R. 3173, the "Improving Seniors’ Timely Access to Care Act of 2021."

AAO Commends Congress for Reaching Significant Milestone on Prior Authorization Reform Bill
May 16, 2022
Spark Therapeutics’ CEO and Founder Jeff Marrazzo Steps Down, COO Ron Philip to Succeed

Spark Therapeutics, a part of the Roche Group, announced that Ron Philip, the company's COO, will take over as CEO from co-founder Jeffrey D. Marrazzo. Mr. Marrazzo, who joined the company as a co-founder in 2013, will step down on April 1.

Spark Therapeutics’ CEO and Founder Jeff Marrazzo Steps Down, COO Ron Philip to Succeed
February 25, 2022
Rayner Acquires Stake in Surgical Instrument Belgian Manufacturer Hasa Optix

Rayner announced that it has entered into a commercial partnership and concurrently acquired a stake in Hasa Optix, a Brussels-based manufacturer of single use ophthalmic surgical instruments and instrument sets.

Rayner Acquires Stake in Surgical Instrument Belgian Manufacturer Hasa Optix
June 09, 2022
Michael Bolle Appointed Designated Chairman of Carl Zeiss AG Supervisory Board

The Carl Zeiss AG shareholders have named Michael Bolle, PhD, as a new Supervisory Board member to represent the Carl Zeiss Foundation, the company's sole shareholder. In January 2022, he will be elected Chairman of the Carl Zeiss AG Supervisory Board.

Michael Bolle Appointed Designated Chairman of Carl Zeiss AG Supervisory Board
December 20, 2021
Retina Consultants of America Announces Addition of Colorado Retina Associates

Retina Consultants of America (RCA), a physician management services company, has added Colorado Retina Associates (CRA) to its national consortium.

Retina Consultants of America Announces Addition of Colorado Retina Associates
October 21, 2021
Nacuity Pharmaceuticals Receives $16.5 Million Series B Financing to Support its Clinical Trials

Nacuity Pharmaceuticals announced the closing of a $16.5 million Series B financing led by Foundation Fighting Blindness and its venture arm RD Fund. Additional existing investors also participated in the round.

Nacuity Pharmaceuticals Receives $16.5 Million Series B Financing to Support its Clinical Trials
June 16, 2022
Omeros Completes Sale of Omidria Franchise to Rayner Surgical

Omeros has completed the sale of Omidria (phenylephrine and ketorolac intraocular solution) 1.0%/0.3% to Rayner Surgical Group.

Omeros Completes Sale of Omidria Franchise to Rayner Surgical
December 29, 2021
AffaMed Signs Licensing Agreement with Hanmi Pharma for Investigational Dry AMD Treatment in Greater China

AffaMed Therapeutics and Hanmi Pharmaceutical Co. have entered into a licensing agreement, according to a company news release.

AffaMed Signs Licensing Agreement with Hanmi Pharma for Investigational Dry AMD Treatment in Greater China
January 05, 2022
BRIM Biotechnology Enters OTC Trading in Taiwan

BRIM Biotechnology has entered OTC trading in Taiwan on June 23, 2022. Established in 2013, BRIM is a clinical-stage company developing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases.

BRIM Biotechnology Enters OTC Trading in Taiwan
June 29, 2022
Retina Consultants of America Acquires Retina Center Northwest

Retina Consultants of America (RCA), a physician management services organization, has added Retina Center Northwest (RCNW) in Washington state,.

Retina Consultants of America Acquires Retina Center Northwest
March 29, 2022
Daha fazla